Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse

Area of Science:

• Vascular Biology
• Hematology
• Physiology

Background:

• Sickle cell disease is characterized by endothelial dysfunction and altered microvascular responses.
• Transgenic sickle mouse models exhibit intravascular sickling and red blood cell adhesion.
• Nitric oxide (NO) plays a crucial role in regulating vascular tone and microcirculation.

Purpose of the Study:

• To investigate the impact of sickle cell disease pathophysiology on nitric oxide (NO)-mediated microvascular responses and hemodynamics in transgenic mice.
• To determine if increased endothelial nitric oxide synthase (eNOS) activity in sickle mice affects vascular tone and blood pressure.

Main Methods:

• Comparison of mean arterial pressure (MAP) and arteriolar responses in transgenic sickle mice and control groups.
• Pharmacological inhibition of nitric oxide synthase (NOS) using N(G)-nitro-L-arginine methyl ester (L-NAME) and aminoguanidine.
• Assessment of arteriolar dilation in response to NO-mediated vasodilators (acetylcholine, sodium nitroprusside) and a cAMP-activating agent (forskolin).

Main Results:

• Transgenic sickle mice displayed lower MAP and increased eNOS expression compared to controls.
• NOS inhibition (L-NAME) increased MAP and constricted arterioles in both groups, confirming NOS activity.
• Transgenic mice showed reduced arteriolar dilation to NO-mediated vasodilators (ACh, SNP) but comparable dilation to forskolin.

Conclusions:

• Increased eNOS/NO activity in transgenic sickle mice contributes to lower blood pressure and diminished arteriolar responses to NO-mediated vasodilators.
• Elevated NO activity may partially compensate for sickle-related flow abnormalities but could also lead to pathological vascular tone changes.
• These findings highlight the complex role of the NO pathway in sickle cell pathophysiology.